News Novo hopes data will boost new insulin in US and Germany Novo Nordisk hopes that new data supporting the cardiovascular and glycaemic safety of its Tresiba long-acting insulin will prove a game-changer in the US.
News Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien... Companies awaiting CV outcomes trial, and court decision in patent case
News Senate could back Trump health law by 4th July, despite warn... Reforms could take away health insurance from 23 million, and deny insurance to those with pre-existing conditions, such as diabetes
News ADA to re-evaluate tweet ban after backlash ADA says photo ban is to protect intellectual property.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face